Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on January 28, 2019. The filing primarily serves to announce the Company's results of operations for the quarter ended December 31, 2018, and to provide detailed updates regarding its asbestos liability exposure and related litigation activities.
Key Financial Metrics: Asbestos Liability and Costs
The filing does not provide standard operating metrics such as revenue, net income, or cash flow from operations; these are referenced in the attached press release (Exhibit 99.1). The following financial data pertains specifically to asbestos-related costs and liabilities:
- Total Asbestos Liability: $517 million as of December 31, 2018 (down from $696 million recorded in 2016).
- Current Portion of Liability: $66 million, representing estimated costs to be paid within the next twelve months.
- Insurance Receivable Asset: $91 million as of December 31, 2018 (representing probable reimbursements).
- Total Costs Incurred (2018): $88.8 million (comprising $63.0 million in settlement/indemnity costs and $25.8 million in defense costs).
- Net Pre-tax Cash Payments (2018): $63.9 million (after insurance receipts of $24.1 million).
- Pending Claims: 29,089 claims as of December 31, 2018.
Material Changes and Litigation Updates
The Company reported no change to its estimated asbestos liability for the period ended December 31, 2018, as actual experience approximated assumptions. Significant litigation developments include:
- Richard DeLisle Claim (Florida): The Supreme Court of Florida reversed a prior appellate decision in favor of the Company, reinstating the trial court's judgment. The Company paid the judgment on December 28, 2018, reflected in Q4 2018 indemnity amounts.
- James Nelson Claim (Pennsylvania): The Company settled this matter following a Supreme Court denial of plaintiff appeal; the settlement was reflected in Q2 2018.
- Lee Holdsworth Claim (New York): The Company settled this matter after a court granted a new trial on joint-and-several liability; the settlement was reflected in Q4 2016.
- James Poage Claim (Missouri): The Company settled this matter after the U.S. Supreme Court denied review; the settlement was reflected in Q2 2018.
- George Coulbourn Claim (Arizona): The Company settled this matter after the Ninth Circuit affirmed the judgment; the settlement was reflected in Q2 2018.
Outlook, Risks, and Management Commentary
Management maintains that the liability estimate through 2059 is reasonable based on stabilized mesothelioma claim filings, favorable case law trends, and state legislative restrictions on claims. The Company has "coverage-in-place" agreements with eleven excess insurer groups and has settled obligations with ten other groups for an aggregate of $82.5 million.
Risks and Uncertainties:
- Estimates are subject to significant uncertainty regarding the timing, severity, and quantity of future claims.
- Changes in the number of new mesothelioma claims, average settlement costs, dismissal rates, or defense costs could materially alter the liability estimate.
- Legislative solutions, structured settlements, or significant adverse verdicts could impact the liability.
- Insurance recoveries depend on the financial viability of insurers and the interpretation of policy terms.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for standard operating metrics (revenue, profit, margins) not detailed in this 8-K text.
- Verify the $517 million asbestos liability balance and the $91 million insurance receivable on the balance sheet.
- Monitor the $66 million current portion of the asbestos liability for cash flow impact in the upcoming year.
- Assess the impact of the $63.9 million net cash outflow for asbestos costs on overall liquidity.
- Track the status of the 29,089 pending claims, particularly the concentration in New York (approx. 18,000 claims).